This past week, the TSX has been riding a wave of optimism, buoyed by expectations of potential interest-rate cuts in the United States. However, the index recently snapped an impressive eight-session winning streak after data revealed that Canada’...
Jonathon Brown
|
August 22, 2024
|
“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson
|
July 2, 2024
|
Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon
|
September 27, 2023
|
GlucoTrack ( NDAQ:GCTK ) is an American medical device company focused on design, development and commercialization. The company is developing proprietary painless and non-invasive blood glucose monitoring devices for both Type 2 diabetes and prediabetes, a market almost ...
Simon Druker
|
January 16, 2023
|
(Image via BlackBerry Limited.) From short-term healthcare plays, long-term technology bets, to uncertain cannabis swings … small-cap investors have had their hands full keeping up with the markets over the past few months. We’ve noted that each...
Stockhouse Editorial
|
May 4, 2022
|
When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...
Dave Jackson
|
December 15, 2021
|
Expecting the markets to be relaxed heading into the holidays? Hardly. Many investors and brokers know that this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is staying active. This past week, it seems ma...
Stockhouse Editorial
|
December 7, 2021
|
Back in early September , we introduced our Stockhouse audience to a unique play in the emerging medical tech space – Neovasc Inc. ( TSX: NVCN , OTCQB: NVCN , Forum ). The company develops, manufactures, and markets products for the rapidly growing cardiovascular marke...
Dave Jackson
|
November 29, 2021
|
(Image via Ivanhoe Mines Ltd.) As November draws to a close, what are investors thankful for? Even if the US Thanksgiving is something you don’t celebrate, major stock markets hovering around record highs recently could be some cause for celebration....
Stockhouse Editorial
|
November 24, 2021
|
Following news that it expects revenue for Q3 2021 to be at least $8 million, resulting in total revenue for the nine months ended September 30, 2021 of at least $22 million (twice as much as that period, last year), PyroGenesis Canada Inc. ( TSX-V.PYR , Forum ) announ...
Stockhouse Editorial
|
November 3, 2021
|